Advisor Group’s Myovant Sciences Ltd. MYOV Stock Holding History

Advisor Group’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,000	Closed	-$5K	–	5506
2019 Q3	$5K	Buy	+1,000	New	+$7.42K	﹤0.01%	4697

Other funds holding MYOV

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

NCM

NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Advisor Group's MYOV Position: Q4 2019 in Review

Advisor Group sold out of Myovant Sciences Ltd. (MYOV) in Q4 2019, closing a stake of 1,000 shares — an estimated $5K sold.

Advisor Group first reported a position in MYOV in Q3 2019 and held it in 1 quarter. The position peaked at $5K in Q3 2019. 77 funds tracked by Wall St. Rank hold MYOV as of Q4 2019.

Advisor Group reported no remaining Myovant Sciences Ltd. position as of Q4 2019 after selling out during the quarter.
Advisor Group sold 1,000 Myovant Sciences Ltd. shares in Q4 2019, an estimated $5K.
Advisor Group first reported a position in Myovant Sciences Ltd. in Q3 2019 and held it in 1 quarter.
Advisor Group's Myovant Sciences Ltd. position peaked at $5K in Q3 2019.
77 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.